Publications 2019

Berlin I, Tonstad S (2019)
It's Time to Bury the "Smoker's Paradox"
Nicotine Tob Res, 21 (9), 1149-1150
DOI 10.1093/ntr/ntz106, PubMed 31231769

O'Brien EC, Segurado R, Geraghty AA, Alberdi G, Rogozinska E, Astrup A, Barakat Carballo R, Bogaerts A, Cecatti JG, Coomarasamy A, de Groot CJM, Devlieger R, Dodd JM, El Beltagy N, Facchinetti F, Geiker N, Guelfi K, Haakstad L, Harrison C, Hauner H, Jensen DM, Khan K, Kinnunen TI, Luoto R, Willem Mol B et al. (2019)
Impact of maternal education on response to lifestyle interventions to reduce gestational weight gain: individual participant data meta-analysis
BMJ Open, 9 (8), e025620
DOI 10.1136/bmjopen-2018-025620, PubMed 31375602

Sundfør TM, Svendsen M, Heggen E, Dushanov S, Klemsdal TO, Tonstad S (2019)
BMI modifies the effect of dietary fat on atherogenic lipids: a randomized clinical trial
Am J Clin Nutr (in press)
DOI 10.1093/ajcn/nqz113, PubMed 31216575

Publications 2018

Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, Tonstad S, Vatten LJ, Riboli E, Norat T (2018)
Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies
Am J Clin Nutr, 108 (5), 1069-1091
DOI 10.1093/ajcn/nqy097, PubMed 30475962

Benowitz NL, Pipe A, West R, Hays JT, Tonstad S, McRae T, Lawrence D, St Aubin L, Anthenelli RM (2018)
Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial
JAMA Intern Med, 178 (5), 622-631
DOI 10.1001/jamainternmed.2018.0397, PubMed 29630702

Botteri E, de Lange T, Tonstad S, Berstad P (2018)
Exploring the effect of a lifestyle intervention on cancer risk: 43-year follow-up of the randomized Oslo diet and antismoking study
J Intern Med, 284 (3), 282-291
DOI 10.1111/joim.12765, PubMed 29790221

Dusanov S, Ruzzin J, Kiviranta H, Klemsdal TO, Retterstøl L, Rantakokko P, Airaksinen R, Djurovic S, Tonstad S (2018)
Associations between persistent organic pollutants and metabolic syndrome in morbidly obese individuals
Nutr Metab Cardiovasc Dis, 28 (7), 735-742
DOI 10.1016/j.numecd.2018.03.004, PubMed 29699815

Jortveit J, Kaldal A, Tonstad S (2018)
Prevalence of diabetes before and after first diagnosis of coronary artery disease
Tidsskr Nor Laegeforen, 138 (5)
DOI 10.4045/tidsskr.17.0539, PubMed 29513466

Sundfør TM, Svendsen M, Tonstad S (2018)
Intermittent calorie restriction-a more effective approach to weight loss?
Am J Clin Nutr, 108 (5), 909-910
DOI 10.1093/ajcn/nqy288, PubMed 30475966

Sundfør TM, Svendsen M, Tonstad S (2018)
Effect of intermittent versus continuous energy restriction on weight loss, maintenance and cardiometabolic risk: A randomized 1-year trial
Nutr Metab Cardiovasc Dis, 28 (7), 698-706
DOI 10.1016/j.numecd.2018.03.009, PubMed 29778565

Sundfør TM, Tonstad S, Svendsen M (2018)
Effects of intermittent versus continuous energy restriction for weight loss on diet quality and eating behavior. A randomized trial
Eur J Clin Nutr, 73 (7), 1006-1014
DOI 10.1038/s41430-018-0370-0, PubMed 30514879

Publications 2017

Aune D, Giovannucci E, Boffetta P, Fadnes LT, Keum N, Norat T, Greenwood DC, Riboli E, Vatten LJ, Tonstad S (2017)
Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies
Int J Epidemiol, 46 (3), 1029-1056
DOI 10.1093/ije/dyw319, PubMed 28338764

Aune D, Schlesinger S, Henriksen T, Saugstad OD, Tonstad S (2017)
Physical activity and the risk of preterm birth: a systematic review and meta-analysis of epidemiological studies
BJOG, 124 (12), 1816-1826
DOI 10.1111/1471-0528.14672, PubMed 28374930

Aune D, Sen A, Leitzmann MF, Norat T, Tonstad S, Vatten LJ (2017)
Body mass index and physical activity and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies
Eur J Nutr, 56 (8), 2423-2438
DOI 10.1007/s00394-017-1443-x, PubMed 28393286

Aune D, Sen A, Leitzmann MF, Tonstad S, Norat T, Vatten LJ (2017)
Tobacco smoking and the risk of diverticular disease - a systematic review and meta-analysis of prospective studies
Colorectal Dis, 19 (7), 621-633
DOI 10.1111/codi.13748, PubMed 28556447

Aune D, Sen A, ó'Hartaigh B, Janszky I, Romundstad PR, Tonstad S, Vatten LJ (2017)
Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - A systematic review and dose-response meta-analysis of prospective studies
Nutr Metab Cardiovasc Dis, 27 (6), 504-517
DOI 10.1016/j.numecd.2017.04.004, PubMed 28552551

Aune D, Sen A, Schlesinger S, Norat T, Janszky I, Romundstad P, Tonstad S, Riboli E, Vatten LJ (2017)
Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies
Eur J Epidemiol, 32 (3), 181-192
DOI 10.1007/s10654-017-0232-4, PubMed 28194602

Heggen E, Svendsen M, Tonstad S (2017)
Smoking cessation improves cardiometabolic risk in overweight and obese subjects treated with varenicline and dietary counseling
Nutr Metab Cardiovasc Dis, 27 (4), 335-341
DOI 10.1016/j.numecd.2016.12.011, PubMed 28216282

Klemsdal TO, Gjelsvik B, Elling I, Johansen S, Kjeldsen SE, Kristensen O, Madsen S, Njolstad I, Selmer R, Tonstad S, Voie H (2017)
New guidelines for the prevention of cardiovascular disease
Tidsskr. Nor. Laegeforen., 137 (16), 1164-1168

Klemsdal TO, Gjelsvik B, Elling I, Johansen S, Kjeldsen SE, Kristensen Ø, Madsen S, Njølstad I, Selmer R, Tonstad S, Voie H (2017)
New guidelines for the prevention of cardiovascular disease
Tidsskr Nor Laegeforen, 137 (16)
DOI 10.4045/tidsskr.17.0109, PubMed 28871738

Klemsdal TO, Gjelsvik B, Elling I, Johansen S, Kjeldsen SE, Kristensen Ø, Madsen S, Njølstad I, Selmer R, Tonstad S, Voie H (2017)
Nye retningslinjer for forebygging av hjerte- og karsykdom
Tidsskr Nor Laegeforen, 137 (19)
DOI 10.4045/tidsskr.17.0794, PubMed 29043734

Rogozińska E, Marlin N, Jackson L, Rayanagoudar G, Ruifrok AE, Dodds J, Molyneaux E, van Poppel MN, Poston L, Vinter CA, McAuliffe F, Dodd JM, Owens J, Barakat R, Perales M, Cecatti JG, Surita F, Yeo S, Bogaerts A, Devlieger R, Teede H, Harrison C, Haakstad L, Shen GX, Shub A et al. (2017)
Effects of antenatal diet and physical activity on maternal and fetal outcomes: individual patient data meta-analysis and health economic evaluation
Health Technol Assess, 21 (41), 1-158
DOI 10.3310/hta21410, PubMed 28795682

Tonstad S (2017)
[Statin intolerance]
Tidsskr Nor Laegeforen, 137 (1), 36-38
DOI 10.4045/tidsskr.16.0646, PubMed 28073228

Tonstad S, Herring P, Lee J, Johnson JD (2017)
Two Physical Activity Measures: Paffenbarger Physical Activity Questionnaire Versus Aerobics Center Longitudinal Study as Predictors of Adult-Onset Type 2 Diabetes in a Follow-Up Study
Am J Health Promot, 32 (4), 1070-1077
DOI 10.1177/0890117117725282, PubMed 28812371

Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E, Ramaswami U (2017)
Statins for children with familial hypercholesterolemia
Cochrane Database Syst Rev, 7, CD006401
DOI 10.1002/14651858.CD006401.pub4, PubMed 28685504

Publications 2016

Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, Tonstad S, Vatten LJ, Riboli E, Norat T (2016)
Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies
BMJ, 353, i2716
DOI 10.1136/bmj.i2716, PubMed 27301975

Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, Tonstad S, Vatten LJ, Riboli E, Norat T (2016)
Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies
BMC Med, 14 (1), 207
DOI 10.1186/s12916-016-0730-3, PubMed 27916000

Aune D, Sen A, Henriksen T, Saugstad OD, Tonstad S (2016)
Physical activity and the risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis of epidemiological studies
Eur J Epidemiol, 31 (10), 967-997
DOI 10.1007/s10654-016-0176-0, PubMed 27485519

Aune D, Sen A, Norat T, Janszky I, Romundstad P, Tonstad S, Vatten LJ (2016)
Body Mass Index, Abdominal Fatness, and Heart Failure Incidence and Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies
Circulation, 133 (7), 639-49
DOI 10.1161/CIRCULATIONAHA.115.016801, PubMed 26746176

Aune D, Sen A, Prasad M, Norat T, Janszky I, Tonstad S, Romundstad P, Vatten LJ (2016)
BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants
BMJ, 353, i2156
DOI 10.1136/bmj.i2156, PubMed 27146380

Dusanov S, Brandal K, Heggen E, Tonstad S (2016)
Associations of Circulating PYY_3-36 Concentrations with Metabolic Syndrome in Extremely Obese Subjects
Metab Syndr Relat Disord, 14 (8), 410-415
DOI 10.1089/met.2016.0031, PubMed 27513679

Dusanov S, Heggen E, Tonstad S (2016)
Characteristics of Metabolic Syndrome in Morbidly Obese Subjects
Metab Syndr Relat Disord, 14 (10), 500-506
DOI 10.1089/met.2016.0062, PubMed 27513810

Flynn AC, Dalrymple K, Barr S, Poston L, Goff LM, Rogozińska E, van Poppel MN, Rayanagoudar G, Yeo S, Barakat Carballo R, Perales M, Bogaerts A, Cecatti JG, Dodd J, Owens J, Devlieger R, Teede H, Haakstad L, Motahari-Tabari N, Tonstad S, Luoto R, Guelfi K, Petrella E, Phelan S, Scudeller TT et al. (2016)
Dietary interventions in overweight and obese pregnant women: a systematic review of the content, delivery, and outcomes of randomized controlled trials
Nutr Rev, 74 (5), 312-28
DOI 10.1093/nutrit/nuw005, PubMed 27083868

Ford PA, Jaceldo-Siegl K, Lee JW, Tonstad S (2016)
Trans fatty acid intake is related to emotional affect in the Adventist Health Study-2
Nutr Res, 36 (6), 509-17
DOI 10.1016/j.nutres.2016.01.005, PubMed 27188896

Kahleova H, Tonstad S, Rosmus J, Fisar P, Mari A, Hill M, Pelikanova T (2016)
The effect of a vegetarian versus conventional hypocaloric diet on serum concentrations of persistent organic pollutants in patients with type 2 diabetes
Nutr Metab Cardiovasc Dis, 26 (5), 430-8
DOI 10.1016/j.numecd.2016.01.008, PubMed 27107842

Larstorp AC, Tonstad S (2016)
Effect of a Low Fat Diet Intervention on Blood Pressure and Hypertension: Rather Switch to a Mediterranean Diet?
Am J Hypertens, 29 (8), 900-3
DOI 10.1093/ajh/hpw054, PubMed 27245068

Masefield S, Powell P, Jiménez-Ruiz C, Hajek P, Lewis K, Andreas S, Tønnesen P, van Schayck O, Gratziou C, Dautzenberg B, Tonstad S, Hering T, Nardini S, Fletcher M (2016)
Recommendations to improve smoking cessation outcomes from people with lung conditions who smoke
ERJ Open Res, 2 (2)
DOI 10.1183/23120541.00009-2016, PubMed 27730185

Rogozinska E, D'Amico MI, Khan KS, Cecatti JG, Teede H, Yeo S, Vinter CA, Rayanagoudar G, Barakat R, Perales M, Dodd JM, Devlieger R, Bogaerts A, van Poppel MN, Haakstad L, Shen GX, Shub A, Luoto R, Kinnunen TI, Phelan S, Poston L, Scudeller TT, El Beltagy N, Stafne SN, Tonstad S et al. (2016)
Development of composite outcomes for individual patient data (IPD) meta-analysis on the effects of diet and lifestyle in pregnancy: a Delphi survey
BJOG, 123 (2), 190-8
DOI 10.1111/1471-0528.13764, PubMed 26841002

Tonstad S, Lawrence D (2016)
Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo-controlled studies of varenicline
J Diabetes Investig, 8 (1), 93-100
DOI 10.1111/jdi.12543, PubMed 27223809

Publications 2015

Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ (2015)
Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis
Eur J Epidemiol, 30 (7), 529-42
DOI 10.1007/s10654-015-0056-z, PubMed 26092138

Griffith L, Haddad EH, Tonstad S (2015)
Postprandial effects of consuming a staggered meal on gut peptide and glycemic responses in obese women and men
Obes Res Clin Pract, 10 (3), 264-74
DOI 10.1016/j.orcp.2015.08.001, PubMed 26311660

Heggen E, Kirkhus B, Pedersen JI, Tonstad S (2015)
Effects of margarine enriched with plant sterol esters from rapeseed and tall oils on markers of endothelial function, inflammation and hemostasis
Scand J Clin Lab Invest, 75 (2), 189-92
DOI 10.3109/00365513.2014.992040, PubMed 25553599

Heggen E, Svendsen M, Klemsdal TO, Tonstad S (2015)
Low Carbohydrate and Moderately Fat-Reduced Diets Similarly Affected Early Weight Gain in Varenicline-Treated Overweight or Obese Smokers
Nicotine Tob Res, 18 (6), 1440-8
DOI 10.1093/ntr/ntv164, PubMed 26242289

Hemmy Asamsama O, Lee JW, Morton KR, Tonstad S (2015)
Bidirectional longitudinal study of type 2 diabetes and depression symptoms in black and white church going adults
J Diabetes Metab Disord, 14, 25
DOI 10.1186/s40200-015-0150-5, PubMed 25897418

Holme I, Tonstad S (2015)
Survival in elderly men in relation to midlife and current BMI
Age Ageing, 44 (3), 434-9
DOI 10.1093/ageing/afu202, PubMed 25609234

Holt ME, Lee JW, Morton KR, Tonstad S (2015)
Trans fatty acid intake and emotion regulation
J Health Psychol, 20 (6), 785-93
DOI 10.1177/1359105315580215, PubMed 26032795

Jiménez-Ruiz CA, Andreas S, Lewis KE, Tonnesen P, van Schayck CP, Hajek P, Tonstad S, Dautzenberg B, Fletcher M, Masefield S, Powell P, Hering T, Nardini S, Tonia T, Gratziou C (2015)
Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit
Eur Respir J, 46 (1), 61-79
DOI 10.1183/09031936.00092614, PubMed 25882805

Khoury J, Knutsen M, Stray-Pedersen B, Thaulow E, Tonstad S (2015)
A lower reduction in umbilical artery pulsatility in mid-pregnancy predicts higher infant blood pressure six months after birth
Acta Paediatr, 104 (8), 796-800
DOI 10.1111/apa.13020, PubMed 25865616

Ruifrok AE, Rogozinska E, van Poppel MN, Rayanagoudar G, Kerry S, de Groot CJ, Yeo S, Molyneaux E, Barakat Carballo R, Perales M, Bogaerts A, Cecatti JG, Surita F, Dodd J, Owens J, El Beltagy N, Devlieger R, Teede H, Harrison C, Haakstad L, Shen GX, Shub A, Motahari N, Khoury J, Tonstad S et al. (2015)
Erratum to: Study protocol: differential effects of diet and physical activity based interventions in pregnancy on maternal and fetal outcomes: individual patient data (IPD) meta-analysis and health economic evaluation
Syst Rev, 4, 101
DOI 10.1186/s13643-015-0079-2, PubMed 26272207

Tonstad S, Jaceldo-Siegl K, Messina M, Haddad E, Fraser GE (2015)
The association between soya consumption and serum thyroid-stimulating hormone concentrations in the Adventist Health Study-2
Public Health Nutr, 19 (8), 1464-70
DOI 10.1017/S1368980015002943, PubMed 26450571

Publications 2014

Alshaeri HK, Natto ZS, Tonstad S, Haddad E, Jaceldo-Siegl K (2014)
Effect of dried California Mission figs on mineral status and food replacement
Public Health Nutr, 18 (6), 1135-40
DOI 10.1017/S1368980014001566, PubMed 25156424

Aune D, Saugstad OD, Henriksen T, Tonstad S (2014)
Physical activity and the risk of preeclampsia: a systematic review and meta-analysis
Epidemiology, 25 (3), 331-43
DOI 10.1097/EDE.0000000000000036, PubMed 24713878

Aune D, Saugstad OD, Henriksen T, Tonstad S (2014)
Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis
JAMA, 311 (15), 1536-46
DOI 10.1001/jama.2014.2269, PubMed 24737366

Holme I, Tonstad S (2014)
Increased predictive ability of BMI but not other risk factors with time in men: 39-year follow-up of total mortality in the Oslo Study
Obes Facts, 7 (5), 311-21
DOI 10.1159/000368567, PubMed 25300406

Holt ME, Lee JW, Morton KR, Tonstad S (2014)
Mediterranean diet and emotion regulation
Med J Nutrition Metab, 7 (3), 163-172
DOI 10.3233/MNM-140016, PubMed 30705744

Jennings C, Kotseva K, De Bacquer D, Hoes A, de Velasco J, Brusaferro S, Mead A, Jones J, Tonstad S, Wood D, EUROACTION PLUS Study Group (2014)
Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial
Eur Heart J, 35 (21), 1411-20
DOI 10.1093/eurheartj/ehu051, PubMed 24616337

Mennen-Winchell LJ, Grigoriev V, Alpert P, Dos Santos H, Tonstad S (2014)
Determinants of vitamin D levels in men receiving androgen deprivation therapy for prostate cancer
J Am Assoc Nurse Pract, 27 (1), 39-47
DOI 10.1002/2327-6924.12122, PubMed 24729531

Serrano S, Lee JW, Dehom S, Tonstad S (2014)
Association of TV watching with sleep problems in a church-going population
Fam Community Health, 37 (4), 279-87
DOI 10.1097/FCH.0000000000000038, PubMed 25167068

Svendsen M, Tonstad S, Heggen E, Pedersen TR, Seljeflot I, Bøhn SK, Bastani NE, Blomhoff R, Holme IM, Klemsdal TO (2014)
The effect of kiwifruit consumption on blood pressure in subjects with moderately elevated blood pressure: a randomized, controlled study
Blood Press, 24 (1), 48-54
DOI 10.3109/08037051.2014.976979, PubMed 25483553

Tonstad S, Gustavsson G, Kruse E, Walmsley JM, Westin Å (2014)
Symptoms of nicotine toxicity in subjects achieving high cotinine levels during nicotine replacement therapy
Nicotine Tob Res, 16 (9), 1266-71
DOI 10.1093/ntr/ntu076, PubMed 24852574

Tonstad S, Nathan E, Oda K, Fraser GE (2014)
Prevalence of hyperthyroidism according to type of vegetarian diet
Public Health Nutr, 18 (8), 1482-7
DOI 10.1017/S1368980014002183, PubMed 25263477

Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E (2014)
Statins for children with familial hypercholesterolemia
Cochrane Database Syst Rev (7), CD006401
DOI 10.1002/14651858.CD006401.pub3, PubMed 25054950

Publications 2013

Batech M, Tonstad S, Job JS, Chinnock R, Oshiro B, Allen Merritt T, Page G, Singh PN (2013)
Estimating the impact of smoking cessation during pregnancy: the San Bernardino County experience
J Community Health, 38 (5), 838-46
DOI 10.1007/s10900-013-9687-8, PubMed 23553684

Davidson MH, Tonstad S, Oparil S, Schwiers M, Day WW, Bowden CH (2013)
Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index ≥27 kg/m(2)
Am J Cardiol, 111 (8), 1131-8
DOI 10.1016/j.amjcard.2012.12.038, PubMed 23375187

Fagerström K, Tonstad S (2013)
Reduced binding to nicotinic receptors after nicotine vaccination: is the effect big enough to be clinically meaningful?
Am J Psychiatry, 170 (4), 359-61
DOI 10.1176/appi.ajp.2012.12121604, PubMed 23545789

Hammoudeh S, Bener A, Zirie M, Al-Hamaq A, Chandra P, Moses O, Dos Santos H, Tonstad S (2013)
The effect of non-exercise activity thermogenesis on subjects with metabolic syndrome - a proof of concept study in Qatar
Qatar Med J, 2013 (1), 12-8
DOI 10.5339/qmj.2013.3, PubMed 25003052

Japas C, Knutsen S, Dehom S, Dos Santos H, Tonstad S (2013)
Body mass index gain between ages 20 and 40 years and lifestyle characteristics of men at ages 40-60 years: the Adventist Health Study-2
Obes Res Clin Pract, 8 (6), e549-57
DOI 10.1016/j.orcp.2013.11.007, PubMed 25434910

Karlsen TI, Lund RS, Røislien J, Tonstad S, Natvig GK, Sandbu R, Hjelmesæth J (2013)
Health related quality of life after gastric bypass or intensive lifestyle intervention: a controlled clinical study
Health Qual Life Outcomes, 11, 17
DOI 10.1186/1477-7525-11-17, PubMed 23406190

Mennen-Winchell LJ, Grigoriev V, Alpert P, Dos Santos H, Tonstad S (2013)
Self-reported exercise and bone mineral density in prostate cancer patients receiving androgen deprivation therapy
J Am Assoc Nurse Pract, 26 (1), 40-8
DOI 10.1002/2327-6924.12066, PubMed 24170604

Tonstad S (2013)
Weight gain does not attenuate cardiovascular benefits of smoking cessation
Evid Based Med, 19 (1), 25
DOI 10.1136/eb-2013-101350, PubMed 23723383

Tonstad S, Heggen E, Giljam H, Lagerbäck PÅ, Tønnesen P, Wikingsson LD, Lindblom N, de Villiers S, Svensson TH, Fagerström KO (2013)
Niccine®, a nicotine vaccine, for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trial
Nicotine Tob Res, 15 (9), 1492-501
DOI 10.1093/ntr/ntt003, PubMed 23471101

Tonstad S, Malik N, Haddad E (2013)
A high-fibre bean-rich diet versus a low-carbohydrate diet for obesity
J Hum Nutr Diet, 27 Suppl 2, 109-16
DOI 10.1111/jhn.12118, PubMed 23627924

Tonstad S, Nathan E, Oda K, Fraser G (2013)
Vegan diets and hypothyroidism
Nutrients, 5 (11), 4642-52
DOI 10.3390/nu5114642, PubMed 24264226

Publications 2012

Ford PA, Jaceldo-Siegl K, Lee JW, Youngberg W, Tonstad S (2012)
Intake of Mediterranean foods associated with positive affect and low negative affect
J Psychosom Res, 74 (2), 142-8
DOI 10.1016/j.jpsychores.2012.11.002, PubMed 23332529

Heggen E, Klemsdal TO, Haugen F, Holme I, Tonstad S (2012)
Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations
Metab Syndr Relat Disord, 10 (6), 437-42
DOI 10.1089/met.2012.0012, PubMed 22889406

Karlsen A, Svendsen M, Seljeflot I, Laake P, Duttaroy AK, Drevon CA, Arnesen H, Tonstad S, Blomhoff R (2012)
Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers
J Hum Hypertens, 27 (2), 126-30
DOI 10.1038/jhh.2011.116, PubMed 22258209

Kolsgaard ML, Joner G, Brunborg C, Anderssen SA, Tonstad S, Andersen LF (2012)
Correction: "Reduction in BMI z-score and improvement in cardiometabolic risk factors in obese children and adolescents. The Oslo adiposity intervention study - a hospital/public health nurse combined treatment."
BMC Pediatr, 12, 77
DOI 10.1186/1471-2431-12-77, PubMed 22709339

Kyulo NL, Knutsen SF, Tonstad S, Fraser GE, Singh PN (2012)
Validation of recall of body weight over a 26-year period in cohort members of the Adventist Health Study 2
Ann Epidemiol, 22 (10), 744-6
DOI 10.1016/j.annepidem.2012.06.106, PubMed 22863312

Sakamoto R, Jaceldo-Siegl K, Haddad E, Oda K, Fraser GE, Tonstad S (2012)
Relationship of vitamin D levels to blood pressure in a biethnic population
Nutr Metab Cardiovasc Dis, 23 (8), 776-84
DOI 10.1016/j.numecd.2012.04.014, PubMed 22770642

Tonstad S, Aubin HJ (2012)
Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial
J Psychopharmacol, 26 (7), 1003-9
DOI 10.1177/0269881111431623, PubMed 22219220

Tonstad S, Job JS, Batech M, Yel D, Kheam T, Singh PN (2012)
Adult tobacco cessation in Cambodia: I. Determinants of quitting tobacco use
Asia Pac J Public Health, 25 (5 Suppl), 10S-9S
DOI 10.1177/1010539512451853, PubMed 22815309

Tonstad S, Job JS, Batech M, Yel D, Kheam T, Singh PN (2012)
Adult tobacco cessation in Cambodia: II. Determinants of intent to quit
Asia Pac J Public Health, 25 (5 Suppl), 20S-32S
DOI 10.1177/1010539512454164, PubMed 22865720

Vollrath ME, Stene-Larsen K, Tonstad S, Rothbart MK, Hampson SE (2012)
Associations between temperament at age 1.5 years and obesogenic diet at ages 3 and 7 years
J Dev Behav Pediatr, 33 (9), 721-7
DOI 10.1097/DBP.0b013e31826bac0d, PubMed 23117597

Publications 2011

Fagerström KO, Gilljam H, Tonstad S (2011)
[Good effect of varenicline in snuff use cessation. Double-blind placebo controlled comparative study]
Lakartidningen, 108 (44), 2215-7
PubMed 22165180

Holme I, Tonstad S (2011)
[Risk factors and mortality--a follow-up of the Oslo Health Study from 1972-73]
Tidsskr Nor Laegeforen, 131 (5), 456-60
DOI 10.4045/tidsskr.10.0342, PubMed 21383797

Holme I, Tonstad S (2011)
Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: the Oslo Study cohort
Eur J Prev Cardiol, 20 (1), 168-75
DOI 10.1177/1741826711432514, PubMed 22131130

Karlsen A, Svendsen M, Seljeflot I, Sommernes MA, Sexton J, Brevik A, Erlund I, Serafini M, Bastani N, Remberg SF, Borge GI, Carlsen MH, Bøhn SK, Myhrstad MC, Dragsted LO, Duttaroy AK, Haffner K, Laake P, Drevon CA, Arnesen H, Collins A, Tonstad S, Blomhoff R (2011)
Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers
Br J Nutr, 106 (4), 557-71
DOI 10.1017/S0007114511000353, PubMed 21806852

Karlsen TI, Tveitå EK, Natvig GK, Tonstad S, Hjelmesæth J (2011)
Validity of the SF-36 in patients with morbid obesity
Obes Facts, 4 (5), 346-51
DOI 10.1159/000333406, PubMed 22166753

Kolsgaard ML, Joner G, Brunborg C, Anderssen SA, Tonstad S, Andersen LF (2011)
Reduction in BMI z-score and improvement in cardiometabolic risk factors in obese children and adolescents. The Oslo Adiposity Intervention Study - a hospital/public health nurse combined treatment
BMC Pediatr, 11, 47
DOI 10.1186/1471-2431-11-47, PubMed 21619652

Norheim OF, Gjelsvik B, Klemsdal TO, Madsen S, Meland E, Narvesen S, Negard A, Njolstad I, Tonstad S, Ulvin F, Wisloff T (2011)
Norway's new principles for primary prevention of cardiovascular disease: age differentiated risk thresholds
BMJ-British Medical Journal, 343, d3626

Peterson JM, Montgomery S, Haddad E, Kearney L, Tonstad S (2011)
Effect of consumption of dried California mission figs on lipid concentrations
Ann Nutr Metab, 58 (3), 232-8
DOI 10.1159/000330112, PubMed 21811062

Paalani M, Lee JW, Haddad E, Tonstad S (2011)
Determinants of inflammatory markers in a bi-ethnic population
Ethn Dis, 21 (2), 142-9
PubMed 21749016

Singh PN, Haddad E, Tonstad S, Fraser GE (2011)
Does excess body fat maintained after the seventh decade decrease life expectancy?
J Am Geriatr Soc, 59 (6), 1003-11
DOI 10.1111/j.1532-5415.2011.03419.x, PubMed 21649624

Svendsen M, Tonstad S (2011)
Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders
Nutr J, 10, 21
DOI 10.1186/1475-2891-10-21, PubMed 21385420

Tonstad S, Després JP (2011)
Treatment of lipid disorders in obesity
Expert Rev Cardiovasc Ther, 9 (8), 1069-80
DOI 10.1586/erc.11.83, PubMed 21878051

Tonstad S, Stewart K, Oda K, Batech M, Herring RP, Fraser GE (2011)
Vegetarian diets and incidence of diabetes in the Adventist Health Study-2
Nutr Metab Cardiovasc Dis, 23 (4), 292-9
DOI 10.1016/j.numecd.2011.07.004, PubMed 21983060

Publications 2010

Aronne LJ, Tonstad S, Moreno M, Gantz I, Erondu N, Suryawanshi S, Molony C, Sieberts S, Nayee J, Meehan AG, Shapiro D, Heymsfield SB, Kaufman KD, Amatruda JM (2010)
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study
Int J Obes (Lond), 34 (5), 919-35
DOI 10.1038/ijo.2010.21, PubMed 20157323

Bøhn SK, Myhrstad MC, Thoresen M, Holden M, Karlsen A, Tunheim SH, Erlund I, Svendsen M, Seljeflot I, Moskaug JO, Duttaroy AK, Laake P, Arnesen H, Tonstad S, Collins A, Drevon CA, Blomhoff R (2010)
Blood cell gene expression associated with cellular stress defense is modulated by antioxidant-rich food in a randomised controlled clinical trial of male smokers
BMC Med, 8, 54
DOI 10.1186/1741-7015-8-54, PubMed 20846424

Fagerström K, Gilljam H, Metcalfe M, Tonstad S, Messig M (2010)
Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial
BMJ, 341, c6549
DOI 10.1136/bmj.c6549, PubMed 21134997

Karlsen A, Paur I, Bøhn SK, Sakhi AK, Borge GI, Serafini M, Erlund I, Laake P, Tonstad S, Blomhoff R (2010)
Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD
Eur J Nutr, 49 (6), 345-55
DOI 10.1007/s00394-010-0092-0, PubMed 20119859

Michelsen TM, Tonstad S, Pripp AH, Tropé CG, Dørum A (2010)
Coronary heart disease risk profile in women who underwent salpingo-oophorectomy to prevent hereditary breast ovarian cancer
Int J Gynecol Cancer, 20 (2), 233-9
DOI 10.1111/IGC.0b013e3181ca5ff4, PubMed 20169665

Peterson RM, Beeson L, Shulz E, Firek A, De Leon M, Balcazar H, Tonstad S, Cordero-Macintyre ZR (2010)
Impacting obesity and glycemic control using a culturally-sensitive diabetes education program in Hispanic patients with type 2 diabetes
Int J Body Compos Res, 8 (3), 85-94
PubMed 21318090

Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S (2010)
Response to Letter Regarding Article, "Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial"
Circulation, 122 (9), E446

Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S (2010)
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial
Circulation, 121 (2), 221-9
DOI 10.1161/CIRCULATIONAHA.109.869008, PubMed 20048210

Solaas K, Legry V, Retterstol K, Berg PR, Holven KB, Ferrières J, Amouyel P, Lien S, Romeo J, Valtueña J, Widhalm K, Ruiz JR, Dallongeville J, Tonstad S, Rootwelt H, Halvorsen B, Nenseter MS, Birkeland KI, Thorsby PM, Meirhaeghe A, Nebb HI (2010)
Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe)
BMC Med Genet, 11, 144
DOI 10.1186/1471-2350-11-144, PubMed 20939869

Tonstad S, Davies S, Flammer M, Russ C, Hughes J (2010)
Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis
Drug Saf, 33 (4), 289-301
DOI 10.2165/11319180-000000000-00000, PubMed 20297861

Tonstad S, Holme I, Tønnesen P (2010)
Dianicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation: a randomized placebo-controlled clinical trial
Nicotine Tob Res, 13 (1), 1-6
DOI 10.1093/ntr/ntq191, PubMed 21041839

Tonstad S, Rollema H (2010)
Varenicline in smoking cessation
Expert Rev Respir Med, 4 (3), 291-9
DOI 10.1586/ers.10.27, PubMed 20524911

Vollrath ME, Tonstad S, Rothbart MK, Hampson SE (2010)
Infant temperament is associated with potentially obesogenic diet at 18 months
Int J Pediatr Obes, 6 (2-2), e408-14
DOI 10.3109/17477166.2010.518240, PubMed 20854098

Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Strandberg T, Tonstad S, Gylling H (2010)
Statins for children with familial hypercholesterolemia
Cochrane Database Syst Rev (7), CD006401
DOI 10.1002/14651858.CD006401.pub2, PubMed 20614444

Publications 2009

Hajek P, Tønnesen P, Arteaga C, Russ C, Tonstad S (2009)
Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment
Addiction, 104 (9), 1597-602
DOI 10.1111/j.1360-0443.2009.02646.x, PubMed 19686530

Halvorsen B, Heggen E, Ueland T, Smith C, Sandberg WJ, Damås JK, Otterdal K, Tonstad S, Aukrust P (2009)
Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
Eur J Endocrinol, 162 (2), 267-73
DOI 10.1530/EJE-09-0706, PubMed 19926782

Hampson SE, Tonstad S, Irgens LM, Meltzer HM, Vollrath ME (2009)
Mothers' negative affectivity during pregnancy and food choices for their infants
Int J Obes (Lond), 34 (2), 327-31
DOI 10.1038/ijo.2009.230, PubMed 19918247

Heggen E, Granlund L, Pedersen JI, Holme I, Ceglarek U, Thiery J, Kirkhus B, Tonstad S (2009)
Plant sterols from rapeseed and tall oils: effects on lipids, fat-soluble vitamins and plant sterol concentrations
Nutr Metab Cardiovasc Dis, 20 (4), 258-65
DOI 10.1016/j.numecd.2009.04.001, PubMed 19748247

Khoury J, Amundsen AL, Tonstad S, Henriksen T, Ose L, Retterstøl K, Iversen PO (2009)
Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia
Acta Obstet Gynecol Scand, 88 (2), 222-6
DOI 10.1080/00016340802503047, PubMed 18972234

Klemsdal TO, Holme I, Nerland H, Pedersen TR, Tonstad S (2009)
Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome
Nutr Metab Cardiovasc Dis, 20 (3), 195-201
DOI 10.1016/j.numecd.2009.03.010, PubMed 19502017

Kolsgaard ML, Wangensteen T, Brunborg C, Joner G, Holven KB, Halvorsen B, Aukrust P, Tonstad S (2009)
Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome
Scand J Clin Lab Invest, 69 (8), 858-64
DOI 10.3109/00365510903348677, PubMed 19929281

Liavaag AH, Tonstad S, Pripp AH, Tropé C, Dørum A (2009)
Prevalence and determinants of metabolic syndrome and elevated Framingham risk score in epithelial ovarian cancer survivors: a controlled observational study
Int J Gynecol Cancer, 19 (4), 634-40
DOI 10.1111/IGC.0b013e3181a13058, PubMed 19509562

Madsen S, Gjelsvik B, Kjeldsen SE, Klemsdal TO, Meland E, Narvesen S, Norheim OF, Njølstad I, Tonstad S, Ulvin F (2009)
[Solid guidelines for prevention of cardiovascular diseases]
Tidsskr Nor Laegeforen, 129 (16), 1660
DOI 10.4045/tidsskr.09.0851, PubMed 19721488

Malterud K, Tonstad S (2009)
Preventing obesity: challenges and pitfalls for health promotion
Patient Educ Couns, 76 (2), 254-9
DOI 10.1016/j.pec.2008.12.012, PubMed 19157764

Svendsen M, Helgeland M, Tonstad S (2009)
The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome
J Hum Nutr Diet, 22 (1), 55-63
DOI 10.1111/j.1365-277X.2008.00920.x, PubMed 19192027

Tonstad S (2009)
Smoking cessation: how to advise the patient
Heart, 95 (19), 1635-40
DOI 10.1136/hrt.2008.154476, PubMed 19752210

Tonstad S (2009)
Cigarette smoking, smoking cessation, and diabetes
Diabetes Res Clin Pract, 85 (1), 4-13
DOI 10.1016/j.diabres.2009.04.013, PubMed 19427049

Tonstad S (2009)
Practical implementation of varenicline as an aid to smoking cessation in clinical practice
Pneumologia, 58 (3), 167-74
PubMed 19817313

Tonstad S, Butler T, Yan R, Fraser GE (2009)
Type of vegetarian diet, body weight, and prevalence of type 2 diabetes
Diabetes Care, 32 (5), 791-6
DOI 10.2337/dc08-1886, PubMed 19351712

Tonstad S, Cowan JL (2009)
C-reactive protein as a predictor of disease in smokers and former smokers: a review
Int J Clin Pract, 63 (11), 1634-41
DOI 10.1111/j.1742-1241.2009.02179.x, PubMed 19732183

Wangensteen T, Kolsgaard ML, Mattingsdal M, Joner G, Tonstad S, Undlien D, Retterstol L (2009)
Mutations in the melanocortin 4 receptor (MC4R) gene in obese patients in Norway
Exp Clin Endocrinol Diabetes, 117 (6), 266-73
DOI 10.1055/s-0028-1102942, PubMed 19301229

Aasen G, Fagertun H, Tonstad S, Halse J (2009)
Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men
Scand J Clin Lab Invest, 69 (2), 181-9
DOI 10.1080/00365510802464641, PubMed 18937100

Publications 2008

Dørum A, Tonstad S, Liavaag AH, Michelsen TM, Hildrum B, Dahl AA (2008)
Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2)
Gynecol Oncol, 109 (3), 377-83
DOI 10.1016/j.ygyno.2008.02.025, PubMed 18407340

Ellingsen I, Seljeflot I, Arnesen H, Tonstad S (2008)
Vitamin C consumption is associated with less progression in carotid intima media thickness in elderly men: A 3-year intervention study
Nutr Metab Cardiovasc Dis, 19 (1), 8-14
DOI 10.1016/j.numecd.2008.01.006, PubMed 18472409

Halvorsen LK, Tonstad S (2008)
[The metabolic syndrome among obese patients]
Tidsskr Nor Laegeforen, 128 (20), 2305-7
PubMed 19096484

Hustvedt BE, Svendsen M, Løvø A, Ellegård L, Hallén J, Tonstad S (2008)
Validation of ActiReg to measure physical activity and energy expenditure against doubly labelled water in obese persons
Br J Nutr, 100 (1), 219-26
DOI 10.1017/S0007114507886363, PubMed 18197993

Jenssen TG, Tonstad S, Claudi T, Midthjell K, Cooper J (2008)
The gap between guidelines and practice in the treatment of type 2 diabetes A nationwide survey in Norway
Diabetes Res Clin Pract, 80 (2), 314-20
DOI 10.1016/j.diabres.2007.12.025, PubMed 18279994

Kolsgaard ML, Andersen LF, Tonstad S, Brunborg C, Wangensteen T, Joner G (2008)
Ethnic differences in metabolic syndrome among overweight and obese children and adolescents: the Oslo Adiposity Intervention Study
Acta Paediatr, 97 (11), 1557-63
DOI 10.1111/j.1651-2227.2008.00955.x, PubMed 18657125

Madsen EL, Rissanen A, Bruun JM, Skogstrand K, Tonstad S, Hougaard DM, Richelsen B (2008)
Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study
Eur J Endocrinol, 158 (2), 179-87
DOI 10.1530/EJE-07-0721, PubMed 18230824

Michelsen TM, Pripp AH, Tonstad S, Tropé CG, Dørum A (2008)
Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study
Eur J Cancer, 45 (1), 82-9
DOI 10.1016/j.ejca.2008.09.028, PubMed 19008092

Svendsen M, Rissanen A, Richelsen B, Rössner S, Hansson F, Tonstad S (2008)
Effect of orlistat on eating behavior among participants in a 3-year weight maintenance trial
Obesity (Silver Spring), 16 (2), 327-33
DOI 10.1038/oby.2007.82, PubMed 18239640

Søgaard AJ, Meyer HE, Tonstad S, Håheim LL, Holme I (2008)
Weight cycling and risk of forearm fractures: a 28-year follow-up of men in the Oslo Study
Am J Epidemiol, 167 (8), 1005-13
DOI 10.1093/aje/kwm384, PubMed 18303007

Publications 2007

Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Frøland SS, Krohg-Sørensen K, Russell D, Aukrust P, Halvorsen B (2007)
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization
Circulation, 115 (8), 972-80
DOI 10.1161/CIRCULATIONAHA.106.665893, PubMed 17283255

Ellingsen I, Hjerkinn EM, Seljeflot I, Arnesen H, Tonstad S (2007)
Consumption of fruit and berries is inversely associated with carotid atherosclerosis in elderly men
Br J Nutr, 99 (3), 674-81
DOI 10.1017/S0007114507832521, PubMed 17894919

Erondu N, Addy C, Lu K, Mallick M, Musser B, Gantz I, Proietto J, Astrup A, Toubro S, Rissannen AM, Tonstad S, Haynes WG, Gottesdiener KM, Kaufman KD, Amatruda JM, Heymsfield SB (2007)
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine
Obesity (Silver Spring), 15 (8), 2027-42
DOI 10.1038/oby.2007.242, PubMed 17712121

Fagerberg B, Schuster H, Birketvedt GS, Tonstad S, Ohman KP, Gause-Nilsson I, SIR Study Group (2007)
Improvement of postprandial lipid handling and glucose tolerance in a non-diabetic population by the dual PPARalpha/gamma agonist, tesaglitazar
Diab Vasc Dis Res, 4 (3), 174-80
DOI 10.3132/dvdr.2007.038, PubMed 17907107

Halvorsen B, Lund Sagen E, Ueland T, Aukrust P, Tonstad S (2007)
Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease
Scand J Clin Lab Invest, 67 (6), 604-11
DOI 10.1080/00365510701283878, PubMed 17852807

Holme I, Sogaard AJ, Haheim LL, Larsen PG, Tonstad S (2007)
Repeated Weight Loss is Associated with the Metabolic Syndrome and Diabetes: Results of a 28 Year Re-screening of Men in the Oslo Study
Metab Syndr Relat Disord, 5 (2), 127-35
DOI 10.1089/met.2007.0003, PubMed 18370821

Holme I, Tonstad S, Sogaard AJ, Larsen PG, Haheim LL (2007)
Leisure time physical activity in middle age predicts the metabolic syndrome in old age: results of a 28-year follow-up of men in the Oslo study
BMC Public Health, 7, 154
DOI 10.1186/1471-2458-7-154, PubMed 17625024

Håheim LL, Tonstad S, Hjermann I, Leren P, Holme I (2007)
Predictiveness of body mass index for fatal coronary heart disease in men according to length of follow-up: a 21-year prospective cohort study
Scand J Public Health, 35 (1), 4-10
DOI 10.1080/14034940510032293, PubMed 17366081

Khoury J, Haugen G, Tonstad S, Frøslie KF, Henriksen T (2007)
Effect of a cholesterol-lowering diet during pregnancy on maternal and fetal Doppler velocimetry: the CARRDIP study
Am J Obstet Gynecol, 196 (6), 549.e1-7
DOI 10.1016/j.ajog.2007.01.017, PubMed 17547890

Khoury J, Henriksen T, Seljeflot I, Mørkrid L, Frøslie KF, Tonstad S (2007)
Effects of an antiatherogenic diet during pregnancy on markers of maternal and fetal endothelial activation and inflammation: the CARRDIP study
BJOG, 114 (3), 279-88
DOI 10.1111/j.1471-0528.2006.01187.x, PubMed 17217362

Richelsen B, Tonstad S, Rössner S, Toubro S, Niskanen L, Madsbad S, Mustajoki P, Rissanen A (2007)
Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study
Diabetes Care, 30 (1), 27-32
DOI 10.2337/dc06-0210, PubMed 17192328

Schuster H, Fagerberg B, Edwards S, Halmos T, Lopatynski J, Stender S, Birketvedt GS, Tonstad S, Gause-Nilsson I, Halldórsdóttir S, Ohman KP, SIR Investigators (2007)
Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance
Atherosclerosis, 197 (1), 355-62
DOI 10.1016/j.atherosclerosis.2007.05.029, PubMed 17631296

Stein EA, Ose L, Retterstøl K, Tonstad S, Schleman M, Harris S, Sager P (2007)
Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia
J Clin Lipidol, 1 (4), 280-6
DOI 10.1016/j.jacl.2007.07.003, PubMed 21291692

Svendsen M, Blomhoff R, Holme I, Tonstad S (2007)
The effect of an increased intake of vegetables and fruit on weight loss, blood pressure and antioxidant defense in subjects with sleep related breathing disorders
Eur J Clin Nutr, 61 (11), 1301-11
DOI 10.1038/sj.ejcn.1602652, PubMed 17268408

Tonstad S (2007)
Varenicline for smoking cessation
Expert Rev Neurother, 7 (2), 121-7
DOI 10.1586/14737175.7.2.121, PubMed 17286546

Tonstad S (2007)
Identifying obese women most at risk from cardiovascular disease
Int J Obes (Lond), 31 Suppl 2, S19-25; discussion S31-2
DOI 10.1038/sj.ijo.0803732, PubMed 17968433

Tonstad S, Retterstøl K, Ose L, Ohman KP, Lindberg MB, Svensson M (2007)
The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin
Metabolism, 56 (9), 1285-92
DOI 10.1016/j.metabol.2007.05.003, PubMed 17697874

Tonstad S, Sandvik E, Larsen PG, Thelle D (2007)
Gender differences in the prevalence and determinants of the metabolic syndrome in screened subjects at risk for coronary heart disease
Metab Syndr Relat Disord, 5 (2), 174-82
DOI 10.1089/met.2006.0037, PubMed 18370825

Tonstad S, Sundfør T, Myrvoll EA (2007)
[Nutritional status after surgical treatment of obesity]
Tidsskr Nor Laegeforen, 127 (1), 50-3
PubMed 17205091

Tonstad S, Thorsrud H, Torjesen PA, Seljeflot I (2007)
Do novel risk factors differ between men and women aged 18 to 39 years with a high risk of coronary heart disease?
Metabolism, 56 (2), 260-6
DOI 10.1016/j.metabol.2006.10.006, PubMed 17224342

Publications 2006

Amundsen AL, Khoury J, Iversen PO, Bergei C, Ose L, Tonstad S, Retterstøl K (2006)
Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia
Atherosclerosis, 189 (2), 451-7
DOI 10.1016/j.atherosclerosis.2006.01.002, PubMed 16466729

Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterstøl K, Iversen PO (2006)
Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
Thromb Res, 120 (1), 21-7
DOI 10.1016/j.thromres.2006.07.001, PubMed 16914186

Bergstrøm H, Tonstad S (2006)
Combined hormone replacement therapy improves lipids but may increase leucocytes
J Intern Med, 259 (5), 537-8
DOI 10.1111/j.1365-2796.2006.01636.x, PubMed 16629858

Ellingsen I, Hjerkinn EM, Arnesen H, Seljeflot I, Hjermann I, Tonstad S (2006)
Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking Study
Eur J Clin Nutr, 60 (3), 378-85
DOI 10.1038/sj.ejcn.1602327, PubMed 16306931

Graff-Iversen S, Hammar N, Thelle DS, Tonstad S (2006)
Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women
Scand J Public Health, 34 (1), 11-6
DOI 10.1080/14034940510032239, PubMed 16449039

Holme I, Søgaard AJ, Lund-Larsen PG, Tonstad S, Håheim LL (2006)
[Is a healthy lifestyle worthwhile?]
Tidsskr Nor Laegeforen, 126 (17), 2246-9
PubMed 16967061

Jorenby DE, Tonstad S, Gonzales D (2006)
Efficacy of varenicline for smoking cessation - Reply
JAMA-J. Am. Med. Assoc., 296 (21), 2555-2556

Lund Håheim L, Holme I, Hjermann I, Tonstad S (2006)
Risk-factor profile for the incidence of subarachnoid and intracerebral haemorrhage, cerebral infarction, and unspecified stroke during 21 years' follow-up in men
Scand J Public Health, 34 (6), 589-97
DOI 10.1080/14034940600731523, PubMed 17132592

Svendsen M, Tonstad S (2006)
Accuracy of food intake reporting in obese subjects with metabolic risk factors
Br J Nutr, 95 (3), 640-9
DOI 10.1079/bjn20051662, PubMed 16512951

Tonstad S (2006)
Is rimonabant a safe and effective therapy for sustained weight loss and improved cardiometabolic risk factors?
Nat Clin Pract Cardiovasc Med, 3 (7), 364-5
DOI 10.1038/ncpcardio0598, PubMed 16810170

Tonstad S (2006)
Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist
J Cardiovasc Nurs, 21 (6), 433-6
DOI 10.1097/00005082-200611000-00004, PubMed 17293731

Tonstad S (2006)
Rimonabant: a cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factors
Nutr Metab Cardiovasc Dis, 16 (2), 156-62
DOI 10.1016/j.numecd.2005.10.011, PubMed 16487916

Tonstad S, Alm CS, Sandvik E (2006)
Effect of nurse counselling on metabolic risk factors in patients with mild hypertension: a randomised controlled trial
Eur J Cardiovasc Nurs, 6 (2), 160-4
DOI 10.1016/j.ejcnurse.2006.07.003, PubMed 16914379

Tonstad S, Andrew Johnston J (2006)
Cardiovascular risks associated with smoking: a review for clinicians
Eur J Cardiovasc Prev Rehabil, 13 (4), 507-14
DOI 10.1097/01.hjr.0000214609.06738.62, PubMed 16874138

Tonstad S, Klemsdal TO, Landaas S, Høieggen A (2006)
No effect of increased water intake on blood viscosity and cardiovascular risk factors
Br J Nutr, 96 (6), 993-6
DOI 10.1017/bjn20061969, PubMed 17181872

Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR, Varenicline Phase 3 Study Group (2006)
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial
JAMA, 296 (1), 64-71
DOI 10.1001/jama.296.1.64, PubMed 16820548

Publications 2005

Bergersen BM, Tonstad S, Sandvik L, Bruun JN (2005)
Low prevalence of high-density lipoprotein cholesterol level < 1 mmol/L in non-nucleoside reverse transcriptase inhibitor recipients
Int J STD AIDS, 16 (5), 365-9
DOI 10.1258/0956462053888808, PubMed 15949067

Fagerberg B, Edwards S, Halmos T, Lopatynski J, Schuster H, Stender S, Stoa-Birketvedt G, Tonstad S, Halldórsdóttir S, Gause-Nilsson I (2005)
Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population
Diabetologia, 48 (9), 1716-25
DOI 10.1007/s00125-005-1846-8, PubMed 16001233

Holme I, Haaheim LL, Tonstad S, Hjermann I (2005)
Effect of dietary and antismoking advice on the incidence of myocardial infarction: a 16-year follow-up of the Oslo Diet and Antismoking Study after its close
Nutr Metab Cardiovasc Dis, 16 (5), 330-8
DOI 10.1016/j.numecd.2005.04.007, PubMed 16829341

Khoury J, Henriksen T, Christophersen B, Tonstad S (2005)
Effect of a cholesterol-lowering diet on maternal, cord, and neonatal lipids, and pregnancy outcome: a randomized clinical trial
Am J Obstet Gynecol, 193 (4), 1292-301
DOI 10.1016/j.ajog.2005.05.016, PubMed 16202717

Stalenhoef AF, Ballantyne CM, Sarti C, Murin J, Tonstad S, Rose H, Wilpshaar W (2005)
A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study
Eur Heart J, 26 (24), 2664-72
DOI 10.1093/eurheartj/ehi482, PubMed 16143705

Tonstad S (2005)
[Drugs for smoking cessation]
Tidsskr Nor Laegeforen, 125 (2), 178-80
PubMed 15665893

Tonstad S, Sundfør T, Seljeflot I (2005)
Effect of lifestyle changes on atherogenic lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease
Am J Cardiol, 95 (10), 1187-91
DOI 10.1016/j.amjcard.2005.01.047, PubMed 15877991

Tonstad S, Svendsen M (2005)
Premature coronary heart disease, cigarette smoking, and the metabolic syndrome
Am J Cardiol, 96 (12), 1681-5
DOI 10.1016/j.amjcard.2005.07.083, PubMed 16360357

Tonstad S, Tykarski A, Weissgarten J, Ivleva A, Levy B, Kumar A, Fitchet M (2005)
Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension
Am J Cardiol, 96 (2), 243-51
DOI 10.1016/j.amjcard.2005.03.053, PubMed 16018851

Wangensteen T, Undlien D, Tonstad S, Retterstøl L (2005)
[Genetic causes of obesity]
Tidsskr Nor Laegeforen, 125 (22), 3090-3
PubMed 16299561

Publications 2004

Bergersen BM, Sandvik L, Bruun JN, Tonstad S (2004)
Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects
Eur J Clin Microbiol Infect Dis, 23 (8), 625-30
DOI 10.1007/s10096-004-1177-6, PubMed 15322938

Graff-Iversen S, Hammar N, Thelle DS, Tonstad S (2004)
Hormone therapy and mortality during a 14-year follow-up of 14 324 Norwegian women
J Intern Med, 256 (5), 437-45
DOI 10.1111/j.1365-2796.2004.01396.x, PubMed 15485480

Halvorsen B, Waehre T, Scholz H, Clausen OP, von der Thüsen JH, Müller F, Heimli H, Tonstad S, Hall C, Frøland SS, Biessen EA, Damås JK, Aukrust P (2004)
Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms
J Lipid Res, 46 (2), 211-9
DOI 10.1194/jlr.M400324-JLR200, PubMed 15547296

Holme I, Tonstad S (2004)
[Treatment with statins of the elderly]
Tidsskr Nor Laegeforen, 124 (2), 167-9
PubMed 14743228

Holme I, Tonstad S, Hjermann I (2004)
[Cardiovascular risk factors among 40-year old men and women in Oslo 1981-1999]
Tidsskr Nor Laegeforen, 124 (23), 3039-42
PubMed 15586182

Håheim LL, Holme I, Hjermann I, Leren P, Tonstad S (2004)
Trends in the incidence of acute myocardial infarction and stroke: a 21-year follow-up of the Oslo study
Scand Cardiovasc J, 38 (4), 216-21
DOI 10.1080/14017430410014910, PubMed 15553932

Klemsdal TO, Tonstad S, Hjermann I (2004)
[How to identify individuals with elevated cardiovascular risk?]
Tidsskr Nor Laegeforen, 124 (6), 799-801
PubMed 15039814

Scholz H, Aukrust P, Damås JK, Tonstad S, Sagen EL, Kolset SO, Hall C, Yndestad A, Halvorsen B (2004)
8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells
Eur J Clin Invest, 34 (7), 451-8
DOI 10.1111/j.1365-2362.2004.01376.x, PubMed 15255781

Tonstad S (2004)
[Should children with familial hypercholesterolemia be treated with statins?]
Lakartidningen, 101 (44), 3406
PubMed 15560654

Tonstad S (2004)
[New trends in the treatment of obesity]
Tidsskr Nor Laegeforen, 124 (3), 391-2
PubMed 14963520

Tonstad S, Furu K, Rosvold EO, Skurtveit S (2004)
Determinants of control of high blood pressure. The Oslo Health Study 2000-2001
Blood Press, 13 (6), 343-9
DOI 10.1080/08037050410003982, PubMed 15771218

Tonstad S, Johnston JA (2004)
Does bupropion have advantages over other medical therapies in the cessation of smoking?
Expert Opin Pharmacother, 5 (4), 727-34
DOI 10.1517/14656566.5.4.727, PubMed 15102559

Tonstad S, Rosvold EO, Furu K, Skurtveit S (2004)
Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001
J Intern Med, 255 (4), 494-502
DOI 10.1111/j.1365-2796.2004.01315.x, PubMed 15049884

Tonstad S, Thompson GR (2004)
Management of Hyperlipidemia in the Pediatric Population
Curr Treat Options Cardiovasc Med, 6 (5), 431-437
PubMed 15324619

Veitenhansl M, Stegner K, Hierl FX, Dieterle C, Feldmeier H, Gutt B, Landgraf R, Garrow AP, Vileikyte L, Findlow A, Waterman C, Boulton AJ, Shankhdhar K, Shankhdhar L, Shankhdhar U, Petrova NL, Foster AV, Edmonds ME, Ferraresi R, Caravaggi C, De Giglio R, Cavaiani P, Pogliaghi I, Sommariva E, Katz IA et al. (2004)
40^th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004
Diabetologia, 47 (Suppl 1), A1-A464
DOI 10.1007/BF03375463, PubMed 27770180

Publications 2003

Ellingsen I, Hjermann I, Abdelnoor M, Hjerkinn EM, Tonstad S (2003)
Dietary and antismoking advice and ischemic heart disease mortality in men with normal or high fasting triacylglycerol concentrations: a 23-y follow-up study
Am J Clin Nutr, 78 (5), 935-40
DOI 10.1093/ajcn/78.5.935, PubMed 14594779

Scholz H, Yndestad A, Damås JK, Waehre T, Tonstad S, Aukrust P, Halvorsen B (2003)
8-isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases
Cardiovasc Res, 59 (4), 945-54
DOI 10.1016/s0008-6363(03)00538-8, PubMed 14553834

Tonstad S (2003)
Choices for treatment of hyperlipidaemia
J Inherit Metab Dis, 26 (2-3), 289-98
DOI 10.1023/A:1024401720730, PubMed 12889667

Tonstad S (2003)
Treatment of children with familial hypercholesterolemia
Expert Rev Cardiovasc Ther, 1 (1), 135-41
DOI 10.1586/14779072.1.1.135, PubMed 15030303

Tonstad S (2003)
Children and statins
Acta Paediatr, 92 (9), 1001-2
DOI 10.1080/08035250310004900, PubMed 14599058

Tonstad S, Farsang C, Klaene G, Lewis K, Manolis A, Perruchoud AP, Silagy C, van Spiegel PI, Astbury C, Hider A, Sweet R (2003)
Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study
Eur Heart J, 24 (10), 946-55
DOI 10.1016/s0195-668x(03)00003-4, PubMed 12714026

Tonstad S, Hjermann I (2003)
A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women
J Cardiovasc Risk, 10 (2), 129-35
DOI 10.1097/01.hjr.0000060837.46105.e7, PubMed 12668910

Tønnesen P, Tonstad S, Hjalmarson A, Lebargy F, Van Spiegel PI, Hider A, Sweet R, Townsend J (2003)
A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation
J Intern Med, 254 (2), 184-92
DOI 10.1046/j.1365-2796.2003.01185.x, PubMed 12859700

Publications 2002

Graff-Iversen S, Tonstad S (2002)
Use of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: results of a population-based cross-sectional Norwegian Survey
Contraception, 66 (1), PII S0010-7824(02)00311-6-13

Graff-Iversen S, Tonstad S (2002)
Use of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: results of a population-based cross-sectional Norwegian Survey
Contraception, 66 (1), 7-13
PubMed 12169374

Os I, Tonstad S (2002)
[Hormone replacement therapy in menopause and cardiovascular disease--one more time]
Tidsskr Nor Laegeforen, 122 (18), 1808-10
PubMed 12362695

Seljeflot I, Tonstad S, Hjermann I, Arnesen H (2002)
Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease
Atherosclerosis, 162 (1), 179-85
DOI 10.1016/s0021-9150(01)00696-7, PubMed 11947912

Seljeflot I, Tonstad S, Hjermann I, Arnesen H (2002)
Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease
Thromb Res, 105 (4), 285-90
DOI 10.1016/s0049-3848(02)00034-8, PubMed 12031821

Tonstad S (2002)
[Bupropion as an aid for smoking cessation]
Tidsskr Nor Laegeforen, 122 (27), 2612-5
PubMed 12523190

Tonstad S (2002)
Use of sustained-release bupropion in specific patient populations for smoking cessation
Drugs, 62 Suppl 2, 37-43
DOI 10.2165/00003495-200262002-00004, PubMed 12109934

Tonstad S, Holme I (2002)
[Treatment with statins: further data from the Heart Protection Study]
Tidsskr Nor Laegeforen, 122 (29), 2777-80
PubMed 12523144

Tonstad S, Smerud K, Høie L (2002)
A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects
Am J Clin Nutr, 76 (1), 78-84
DOI 10.1093/ajcn/76.1.78, PubMed 12081819

Tonstad S, Urdal P (2002)
Does short-term smoking cessation reduce plasma total homocysteine concentrations?
Scand J Clin Lab Invest, 62 (4), 279-84
DOI 10.1080/003655102760145834, PubMed 12476926

Tonstad S, Westheim A (2002)
Implementation of guidelines to screen relatives of patients with premature coronary heart disease in a hospital setting
Am J Cardiol, 90 (11), 1211-4
DOI 10.1016/s0002-9149(02)02836-9, PubMed 12450600

Publications 2001

Johnson LK, Hjermann I, Tonstad S (2001)
[Diet and secondary prevention of coronary heart disease--are our recommendations good enough?]
Tidsskr Nor Laegeforen, 121 (9), 1092-8
PubMed 11354888

Leren TP, Tonstad S, Ose L (2001)
[Familial hypercholesterolemia--prognosis and treatment]
Tidsskr Nor Laegeforen, 121 (13), 1635
PubMed 11446054

Leren TP, Tonstad S, Ose L (2001)
[Genetic screening and treatment in familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 121 (13), 1635-6
PubMed 11446055

Tonstad S (2001)
Stratification of risk in children with familial hypercholesterolemia with focus on psychosocial issues
Nutr Metab Cardiovasc Dis, 11 Suppl 5, 64-7
PubMed 12063779

Tonstad S (2001)
[Zyban in smoking cessation--what about medical ethics?]
Tidsskr Nor Laegeforen, 121 (2), 231
PubMed 11475211

Tonstad S, Graff-Iversen S (2001)
Action levels for obesity treatment in 40 to 42-y-old men and women compared with action levels for prevention of coronary heart disease
Int J Obes Relat Metab Disord, 25 (11), 1698-704
DOI 10.1038/sj.ijo.0801804, PubMed 11753593

Tonstad S, Strøm EC, Bergei CS, Ose L, Christophersen B (2001)
Serum cholesterol response to replacing butter with a new trans-free margarine in hypercholesterolemic subjects
Nutr Metab Cardiovasc Dis, 11 (5), 320-6
PubMed 11887429

Publications 2000

Tonstad S (2000)
Role of lipid-lowering pharmacotherapy in children
Paediatr Drugs, 2 (1), 11-22
DOI 10.2165/00148581-200002010-00002, PubMed 10937455

Tonstad S, Birkeland KI (2000)
[The obesity epidemics--do diet pills have a place in the treatment?]
Tidsskr Nor Laegeforen, 120 (17), 1997-2001
PubMed 11008533

Tonstad S, Hjermann I (2000)
Cardiovascular risk factors and testing of relatives amongst patients with familial hyperlipidaemia one decade after a clinical trial
J Intern Med, 248 (2), 111-8
DOI 10.1046/j.1365-2796.2000.00692.x, PubMed 10947889

Tonstad S, Joakimsen O, Leren TP, Ose L (2000)
Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercholesterolaemia?
Acta Paediatr, 89 (12), 1490-2
DOI 10.1080/080352500456705, PubMed 11195242

Tonstad S, Os I (2000)
[Does postmenopausal hormone replacement therapy have a place in treatment of hyperlipidemia?]
Tidsskr Nor Laegeforen, 120 (8), 923-6
PubMed 10795496

Publications 1999

Delghandi M, Thangarajah R, Nilsen M, Grimsgaard S, Bønaa KH, Tonstad S, Jørgensen L (1999)
DNA polymorphisms of the apolipoprotein B gene (XbaI, EcoRI, and MspI RFLPs) in Norwegians at risk of atherosclerosis and healthy controls
Acta Cardiol, 54 (4), 215-25
PubMed 10511898

Gaudet D, Gagné C, Perron P, Couture P, Tonstad S (1999)
Ethical issues in molecular screening for heterozygous familial hypercholesterolemia: the complexity of dealing with genetic susceptibility to coronary artery disease
Community Genet, 2 (1), 2-8
DOI 10.1159/000016176, PubMed 11658106

Rødningen OK, Tonstad S, Medh JD, Chappell DA, Ose L, Leren TP (1999)
Phenotypic consequences of a deletion of exons 2 and 3 of the LDL receptor gene
J Lipid Res, 40 (2), 213-20
PubMed 9925649

Rødningen OK, Tonstad S, Saugstad OD, Ose L, Leren TP (1999)
Mutant transcripts of the LDL receptor gene: mRNA structure and quantity
Hum Mutat, 13 (3), 186-96
DOI 10.1002/(SICI)1098-1004(1999)13:3<186::AID-HUMU2>3.0.CO;2-K, PubMed 10090473

Tonstad S (1999)
[Nicotine preparations and other preparations for smoking cessation]
Tidsskr Nor Laegeforen, 119 (9), 1289-93
PubMed 10327851

Tonstad S, Gørbitz C, Sivertsen M, Ose L (1999)
Under-reporting of dietary intake by smoking and non-smoking subjects counselled for hypercholesterolaemia
J Intern Med, 245 (4), 337-44
DOI 10.1046/j.1365-2796.1999.00450.x, PubMed 10356595

Publications 1998

Ose L, Vollebaek LE, Tonstad S (1998)
[Attitude to genetic screening for familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 118 (10), 1578-81
PubMed 9615587

Rødningen OK, Tonstad S, Ose L, Berg K, Leren TP (1998)
Effects of a 9.6-kb deletion of the LDL receptor gene (FH Helsinki) on structure and levels of mRNA
Hum Mutat, 12 (2), 95-102
DOI 10.1002/(SICI)1098-1004(1998)12:2<95::AID-HUMU4>3.0.CO;2-E, PubMed 9671270

Sundt E, Ose L, Tonstad S (1998)
[Referrals to the Lipid clinic--"appropriate" patients with inadequate anamnesis]
Tidsskr Nor Laegeforen, 118 (5), 749-52
PubMed 9528374

Tonstad S (1998)
Do genetic determinates of ischaemic heart disease imply that prevention may become more difficult?
J Intern Med, 243 (5), 333-7
PubMed 9651554

Tonstad S (1998)
[Do women need different strategies than men to prevent cardiovascular diseases?]
Tidsskr Nor Laegeforen, 118 (5), 739-42
PubMed 9528372

Tonstad S (1998)
[Should treatment of risk factors of cardiovascular diseases be directed only by absolute risk?]
Tidsskr Nor Laegeforen, 118 (19), 2966-8
PubMed 9748836

Tonstad S, Joakimsen O, Stensland-Bugge E, Ose L, Bønaa KH, Leren TP (1998)
Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects
Eur J Clin Invest, 28 (12), 971-9
PubMed 9893006

Tonstad S, Refsum H, Ose L, Ueland PM (1998)
The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine
J Pediatr, 132 (2), 365-8
DOI 10.1016/s0022-3476(98)70465-2, PubMed 9506661

Publications 1997

Leren TP, Bakken KS, Rødningen OK, Gundersen KE, Sundvold H, Berg K, Tonstad S, Ose L (1997)
[Application of gene technology in the diagnosis of familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 117 (5), 678-81
PubMed 9102960

Leren TP, Tonstad S, Gundersen KE, Bakken KS, Rødningen OK, Sundvold H, Ose L, Berg K (1997)
Molecular genetics of familial hypercholesterolaemia in Norway
J Intern Med, 241 (3), 185-94
DOI 10.1046/j.1365-2796.1997.78119000.x, PubMed 9104431

Svilaas A, Bye P, Strøm EC, Kolbjørnsen O, Tonstad S, Ose L (1997)
[What happens with patients after participation in a clinical trial?]
Tidsskr Nor Laegeforen, 117 (28), 4065-9
PubMed 9441437

Tonstad S (1997)
[Zocor and Sotacor]
Tidsskr Nor Laegeforen, 117 (8), 1187
PubMed 9148500

Tonstad S (1997)
[Biotechnology and familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 117 (21), 3124
PubMed 9381451

Tonstad S (1997)
Correlates of plasma total homocysteine in patients with hyperlipidaemia
Eur J Clin Invest, 27 (12), 1025-9
DOI 10.1046/j.1365-2362.1997.2260772.x, PubMed 9466131

Tonstad S (1997)
[Drug therapy of hyperlipidemia--unanswered questions]
Tidsskr Nor Laegeforen, 117 (5), 674-7
PubMed 9102959

Tonstad S (1997)
A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits
Drug Saf, 16 (5), 330-41
DOI 10.2165/00002018-199716050-00004, PubMed 9187532

Tonstad S, Aksnes L (1997)
Fat-soluble vitamin levels in familial hypercholesterolemia
J Pediatr, 130 (2), 274-80
DOI 10.1016/s0022-3476(97)70354-8, PubMed 9042131

Tonstad S, Leren TP, Ose L (1997)
[Diagnosis and treatment of severe hyperlipidemia]
Tidsskr Nor Laegeforen, 117 (29), 4241-4
PubMed 9441469

Tonstad S, Refsum H, Ueland PM (1997)
Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia
Circulation, 96 (6), 1803-8
DOI 10.1161/01.cir.96.6.1803, PubMed 9323065

Tonstad S, Sivertsen M (1997)
Dietary adherence in children with familial hypercholesterolemia
Am J Clin Nutr, 65 (4), 1018-26
DOI 10.1093/ajcn/65.4.1018, PubMed 9094888

Tonstad S, Sivertsen M (1997)
Relation between dietary fat and energy and micronutrient intakes
Arch Dis Child, 76 (5), 416-20
DOI 10.1136/adc.76.5.416, PubMed 9196356

Urdal P, Leren TP, Tonstad S, Lund PK, Ose L (1997)
Flow cytometric measurement of low density lipoprotein receptor activity validated by DNA analysis in diagnosing heterozygous familial hypercholesterolemia
Cytometry, 30 (5), 264-8
PubMed 9383100

Publications 1996

Gundersen KE, Solberg K, Rødningen OK, Tonstad S, Ose L, Berg K, Leren TP (1996)
Two novel missense mutations in the LDL receptor gene causing familial hypercholesterolemia
Clin Genet, 49 (2), 85-7
DOI 10.1111/j.1399-0004.1996.tb04333.x, PubMed 8740918

Leren TP, Sundvold H, Rodningen OK, Tonstad S, Solberg K, Ose L, Berg K (1996)
Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia (vol 95, pg 671, 1995)
Hum. Genet., 97 (2), 268

Nenseter MS, Volden V, Berg T, Drevon CA, Ose L, Tonstad S (1996)
Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women
Eur J Clin Invest, 26 (12), 1062-8
DOI 10.1046/j.1365-2362.1996.390593.x, PubMed 9013080

Singh PN, Tonstad S, Abbey DE, Fraser GE (1996)
Validity of selected physical activity questions in white Seventh-day Adventists and non-Adventists
Med Sci Sports Exerc, 28 (8), 1026-37
PubMed 8871913

Sundvold H, Solberg K, Tonstad S, Rødningen OK, Ose L, Berg K, Leren TP (1996)
A common missense mutation (C210G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects
Hum Mutat, 7 (1), 70-1
DOI 10.1002/(SICI)1098-1004(1996)7:1<70::AID-HUMU12>3.0.CO;2-P, PubMed 8664907

Tonstad S (1996)
Familial hypercholesterolaemia: a pilot study of parents' and children's concerns
Acta Paediatr, 85 (11), 1307-13
DOI 10.1111/j.1651-2227.1996.tb13916.x, PubMed 8955457

Tonstad S (1996)
Combined hormone replacement therapy with oestradiol and norethisterone acetate: effects in hyperlipidaemia
Br J Obstet Gynaecol, 103 Suppl 13, 45-8
PubMed 8624342

Tonstad S, Joakimsen O, Stensland-Bugge E, Leren TP, Ose L, Russell D, Bønaa KH (1996)
Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects
Arterioscler Thromb Vasc Biol, 16 (8), 984-91
DOI 10.1161/01.ATV.16.8.984, PubMed 8696963

Tonstad S, Knudtzon J, Sivertsen M, Refsum H, Ose L (1996)
Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia
J Pediatr, 129 (1), 42-9
DOI 10.1016/s0022-3476(96)70188-9, PubMed 8757561

Tonstad S, Nøvik TS, Vandvik IH (1996)
Psychosocial function during treatment for familial hypercholesterolemia
Pediatrics, 98 (2 Pt 1), 249-55
PubMed 8692626

Tonstad S, Ose L (1996)
Colestipol tablets in adolescents with familial hypercholesterolaemia
Acta Paediatr, 85 (9), 1080-2
DOI 10.1111/j.1651-2227.1996.tb14221.x, PubMed 8888922

Tonstad S, Refsum H, Sivertsen M, Christophersen B, Ose L, Ueland PM (1996)
Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives
Pediatr Res, 40 (1), 47-52
DOI 10.1203/00006450-199607000-00009, PubMed 8798245

Tonstad S, Sivertsen M, Aksnes L, Ose L (1996)
Low dose colestipol in adolescents with familial hypercholesterolaemia
Arch Dis Child, 74 (2), 157-60
DOI 10.1136/adc.74.2.157, PubMed 8660081

Tonstad S, Sundt E, Ose L, Hagve TA, Fruchart JC, Bard JM, Edén S (1996)
The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein (a) levels in familial hypercholesterolemia
Metabolism, 45 (11), 1415-21
DOI 10.1016/s0026-0495(96)90124-9, PubMed 8931648

Publications 1995

Leren TP, Rødningen OK, Tonstad S, Røsby O, Urdal P, Ose L (1995)
Identification of the apo B-3500 mutation in the Norwegian population
Scand J Clin Lab Invest, 55 (3), 217-21
DOI 10.3109/00365519509089616, PubMed 7638555

Leren TP, Solberg K, Rødningen OK, Tonstad S, Ose L (1995)
Two novel point mutations in the EGF precursor homology domain of the LDL receptor gene causing familial hypercholesterolemia
Hum Genet, 96 (2), 241-2
DOI 10.1007/bf00207391, PubMed 7635482

Leren TP, Sundvold H, Rødningen OK, Tonstad S, Solberg K, Ose L, Berg K (1995)
Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia
Hum Genet, 95 (6), 671-6
DOI 10.1007/bf00209485, PubMed 7789953

Løhne K, Urdal P, Leren TP, Tonstad S, Ose L (1995)
Standardization of a flow cytometric method for measurement of low-density lipoprotein receptor activity on blood mononuclear cells
Cytometry, 20 (4), 290-5
DOI 10.1002/cyto.990200404, PubMed 7587716

Nenseter MS, Volden V, Berg T, Drevon CA, Ose L, Tonstad S (1995)
No effect of beta-carotene supplementation on the susceptibility of low density lipoprotein to in vitro oxidation among hypercholesterolaemic, postmenopausal women
Scand J Clin Lab Invest, 55 (6), 477-85
DOI 10.3109/00365519509075385, PubMed 8571077

Ose L, Tonstad S (1995)
The detection and management of dyslipidaemia in children and adolescents
Acta Paediatr, 84 (11), 1213-5
PubMed 8580613

Ose L, Tonstad S, Vesterhus P, Wefring KW (1995)
[Diagnosis and treatment of familial hypercholesterolemia in children and adolescents]
Tidsskr Nor Laegeforen, 115 (28), 3499-503
PubMed 7491603

Tonstad S (1995)
[Antioxidants and cardiovascular disorders--epidemiologic aspects. Should high risk patients receive supplementation?]
Tidsskr Nor Laegeforen, 115 (2), 227-9
PubMed 7855818

TONSTAD S, BING RF, FROHLICH J, KARPOV Y, OSE L, ROMICS L, STURMER W, PAWSEY SD, ZHANG IX (1995)
EFFECTIVENESS OF COLESTIPOL TABLETS VS GRANULES IN PATIENTS WITH MODERATE TO SEVERE HYPERCHOLESTEROLEMIA
Clin. Drug Invest., 10 (5), 257-263

TONSTAD S, DELANGE P, SIVERTSEN M, OSE L (1995)
PHYSICAL-FITNESS AND FIBRINOGEN LEVELS AMONG HYPERCHOLESTEROLEMIC POSTMENOPAUSAL WOMEN
Nutr. Metab. Carbiovasc. Dis., 5 (2), 93-97

Tonstad S, Holdaas H, Gørbitz C, Ose L (1995)
Is dietary intervention effective in post-transplant hyperlipidaemia?
Nephrol Dial Transplant, 10 (1), 82-5
PubMed 7724035

Tonstad S, Leren TP, Sivertsen M, Ose L (1995)
Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway
Arterioscler Thromb Vasc Biol, 15 (8), 1009-14
DOI 10.1161/01.ATV.15.8.1009, PubMed 7627689

Tonstad S, Ose L, Gørbitz C, Djøseland O, Bard JM, Fruchart JC (1995)
Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women
J Intern Med, 238 (1), 39-47
DOI 10.1111/j.1365-2796.1995.tb00897.x, PubMed 7608645

Tonstad S, Vollebaek LE, Ose L (1995)
Screening for familial hypercholesterolaemia in relatives
Lancet, 346 (8987), 1438
DOI 10.1016/s0140-6736(95)92461-2, PubMed 7475864

Publications 1994

Leren TP, Solberg K, Rødningen OK, Tonstad S, Ose L (1994)
Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects
Atherosclerosis, 111 (2), 175-82
DOI 10.1016/0021-9150(94)90091-4, PubMed 7718019

Nenseter MS, Volden V, Tonstad S, Gudmundsen O, Ose L, Drevon CA (1994)
Modification of low density lipoprotein in relation to intake of fatty acids and antioxidants
World Rev Nutr Diet, 75, 144-8
PubMed 7871817

Solberg K, Rødningen OK, Tonstad S, Ose L, Leren TP (1994)
Familial hypercholesterolaemia caused by a non-sense mutation in codon 329 of the LDL receptor gene
Scand J Clin Lab Invest, 54 (8), 605-9
DOI 10.3109/00365519409087539, PubMed 7709162

Tonstad S, Gørbitz C, Ose L, Malt UF (1994)
[A comparison between lovastatin and pravastatin--effects on lipids, sleep and quality of life in primary hyperlipidemia]
Tidsskr Nor Laegeforen, 114 (19), 2262-4
PubMed 7992293

Tonstad S, Pometta D, Erkelens DW, Ose L, Moccetti T, Schouten JA, Golay A, Reitsma J, Del Bufalo A, Pasotti E (1994)
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia
Eur J Clin Pharmacol, 46 (5), 405-10
DOI 10.1007/bf00191901, PubMed 7957533

TONSTAD S, SIVERTSEN M, LEREN TP, ROSBY O, OSE L (1994)
RESPONSIVENESS TO DIETARY INDULGENCE AMONG PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
Nutr. Metab. Carbiovasc. Dis., 4 (3), 159-162

Publications 1993

Leren TP, Solberg K, Rødningen OK, Ose L, Tonstad S, Berg K (1993)
Evaluation of running conditions for SSCP analysis: application of SSCP for detection of point mutations in the LDL receptor gene
PCR Methods Appl, 3 (3), 159-62
PubMed 8118396

Leren TP, Solberg K, Rødningen OK, Røsby O, Tonstad S, Ose L, Berg K (1993)
Screening for point mutations in exon 10 of the low density lipoprotein receptor gene by analysis of single-strand conformation polymorphisms: detection of a nonsense mutation-FH469-->Stop
Hum Genet, 92 (1), 6-10
DOI 10.1007/bf00216137, PubMed 8103503

Rødningen OK, Leren TP, Røsby O, Tonstad S, Ose L, Berg K (1993)
Haplotype analysis at the low density lipoprotein receptor locus in normal and familial hypercholesterolemia Norwegian subjects
Clin Genet, 44 (4), 214-20
DOI 10.1111/j.1399-0004.1993.tb03883.x, PubMed 7903228

SOLBERG K, RODNINGEN OK, TONSTAD S, OSE L, BERG K, LEREN TP (1993)
MSPL RFLP IN EXON 18 OF THE LDL RECEPTOR GENE DETECTABLE BY PCR
Clin. Genet., 44 (2), 111

Solberg K, Rødningen OK, Tonstad S, Ose L, Berg K, Leren TP (1993)
Short report on DNA marker at candidate locus
Clin Genet, 44 (2), 111
PubMed 8275559

Tonstad S, Ose L, Gørbitz C, Harrison EM, de Koning Gans HJ (1993)
Effectiveness of low-dose lovastatin combined with low-dose colestipol in moderate to severe primary hypercholesterolaemia
Scand J Clin Lab Invest, 53 (5), 457-63
DOI 10.1080/00365519309092540, PubMed 8210967

Publications 1992

Leren TP, Solberg K, Røsby O, Rødningen OK, Tonstad S, Ose L, Berg K (1992)
A new polymorphism in exon 11 of the LDL receptor gene in healthy people and in familial hypercholesterolemia subjects
Clin Genet, 42 (5), 224-8
DOI 10.1111/j.1399-0004.1992.tb03245.x, PubMed 1486698

Rødningen OK, Røsby O, Tonstad S, Ose L, Berg K, Leren TP (1992)
A 9.6 kilobase deletion in the low density lipoprotein receptor gene in Norwegian familial hypercholesterolemia subjects
Clin Genet, 42 (6), 288-95
DOI 10.1111/j.1399-0004.1992.tb03258.x, PubMed 1362925

Røsby O, Poledne R, Hjermann I, Tonstad S, Berg K, Leren TP (1992)
StyI polymorphism in an enhancer region of the second intron of the apolipoprotein B gene in hyper- and hypocholesterolemic subjects
Clin Genet, 42 (5), 217-23
DOI 10.1111/j.1399-0004.1992.tb03244.x, PubMed 1362528

Publications 1991

Lindsted K, Tonstad S, Kuzma JW (1991)
Body mass index and patterns of mortality among Seventh-day Adventist men
Int J Obes, 15 (6), 397-406
PubMed 1885263

Lindsted KD, Tonstad S, Kuzma JW (1991)
Self-report of physical activity and patterns of mortality in Seventh-Day Adventist men
J Clin Epidemiol, 44 (4-5), 355-64
PubMed 2010779

Tonstad S (1991)
[Dietary supplementation in the treatment of hyperlipidemia]
Tidsskr Nor Laegeforen, 111 (28), 3398-400
PubMed 1665257